Interactive Decision Support Tool for HCPs

Share

Program Content

Activities

  • Adjuvant Tx HER2 Negative EBC
    Adjuvant Therapy for HER2-Negative Early Breast Cancer: Interactive Decision Support Tool
    Tool
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 22, 2024

    Expires: August 21, 2025

Faculty

cover img faculity

Laura Huppert, MD

Assistant Professor of Medicine
Division of Hematology/Oncology
University of California, San Francisco
San Francisco, California

cover img faculity

Kevin Kalinsky, MD, MS

Division Director, Medical Oncology
Professor, Department of Hematology and Medical Oncology
Winship Cancer Institute at Emory University
Atlanta, Georgia

cover img faculity

Reshma Mahtani, DO

Chief of Breast Medical Oncology
Miami Cancer Center
Baptist Health South Florida
Miami, Florida

cover img faculity

Laura M. Spring, MD

Breast Medical Oncologist
Mass General Hospital Cancer Center
Harvard Medical School
Boston, Massachusetts

cover img faculity

Tiffany A Traina, MD, FASCO

Associate Attending, Breast Medicine Service
Vice Chair, Department of Medicine
Section Head, TNBC Clinical Research Program
Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine
Weill Cornell Medicine
New York, New York

Provided by

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca, Merck Sharp & Dohme, LLC, and Novartis Pharmaceuticals Corporation.

AstraZeneca

Merck Sharp & Dohme, LLC

Novartis Pharmaceuticals Corporation

Partners

Breastcancer.org

ProCE Banner